Erratum: Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor–Based Regimens in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback